GFRAL and obesity due to melanocortin 4 receptor deficiency: In this review, we will summarise the molecular mechanisms of GDF15‐GFRAL pathway in obesity, and we will also discuss the efficacy of drugs that target the GDF15‐GFRAL pathway for the treatment of obesity and the potential challenges.